Selective seprase inhibitors

Details for Australian Patent Application No. 2009296513 (hide)

Owner Molecular Insight Pharmaceuticals, Inc.

Inventors Zimmerman, Craig; Babich, John W.; Joyal, John; Marquis, John; Wang, Jian-cheng

Agent FB Rice

Pub. Number AU-A-2009296513

PCT Pub. Number WO2010/036814

Priority 61/100,178 25.09.08 US

Filing date 24 September 2009

Wipo publication date 1 April 2010

International Classifications

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07F 5/02 (2006.01) Compounds containing elements of the 3rd Group of the Periodic System

Event Publications

21 April 2011 PCT application entered the National Phase

  PCT publication WO2010/036814 Priority application(s): WO2010/036814

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009296514-Magnetically-levitated blood pump with optimization method enabling miniaturization

2009296510-Device, system and method for directly generating alternating current electricity from photovoltaic cells